Dying Patients Being Denied Access to Life-Saving Treatment


By anh-usa | Alliance for Natural HealthStayStrongandBeatCancer-35524093_m-680x380

The FDA is effectively signing the death warrant of more patients by denying them access to Dr. Burzynski’s antineoplaston cancer treatment—for no rational reason whatsoever. Please help. Action Alert!

Over the years, we’ve covered the FDA’s attacks on Dr. Stanislaw Burzynski, the trailblazing cancer doctor best known for his discovery and development of antineoplastons (ANP), which are peptides and amino acid derivatives that activate tumor-suppressing genes. Independent research has confirmed antineoplastons to be an effective cancer treatment.

As we’ve reported in the past, the conventional medical establishment has, through a succession of relentless attacks, slowly choked off patient access to antineoplastons. In July 2012, after years of failed legal attempts to shutter the Burzynski clinic completely, the FDA told Dr. Burzynski he could no longer accept children for treatment with antineoplastons during the current FDA trial. In January 2013, this ban was extended to adults. This means that under current FDA restrictions, no new patients can be treated with antineoplastons. Terminal cases who could be saved will instead die.

Since the FDA has formally forbidden new patient access to antineoplastons, the only hope of dying patients is to convince the FDA to grant a “compassionate use” or “single-patient protocol” exemption via its expanded access rule. This rule allows for the case-by-case use of an experimental or unapproved drug outside of a clinical trial if a patient has a serious or immediately life-threatening disease or condition, and has no other treatment options left.

For an individual patient to be granted access to an experimental drug in the expanded access rule, a doctor need only conclude that the experimental drug does not pose a greater risk than the disease itself. Despite this rule, the FDA has, on a number of occasions, refused to grant access to antineoplastons for patients for whom the treatment is the last shot at living. In one tragic case, a five-year-old diagnosed with aggressive brain cancer died while waiting for the FDA to approve ANP treatment. The FDA eventually did grant the child compassionate use, but by that time he was already brain dead.

In May of this year, a patient with glioblastoma (GBM) was denied access to Dr. Burzynski’s treatment because the FDA judged that “the potential benefits [did not]justify the potential risks of the treatment.” GBM is a highly malignant form of brain cancer and extremely difficult to treat. Apparently death is less risky for these patients than a natural and effective treatment which has a long history of safe use.

What is both confusing and astonishing is that the FDA representatives who denied the request did not challenge the fact that the antineoplaston treatment has no significant additional side effects when compared to standard cancer therapies. The FDA’s main point of contention seems to be that they consider antineoplastons to be an ineffective treatment for GBM, hence they see no perceived benefit to the treatment. The actual effectiveness of the treatment is not in doubt, however, having been used for many years, but that is supposed to be determined by the current FDA-approved trial.

The government actually agreed to the trial—but only if antineoplastons were combined with conventional chemotherapy, just to muddy the results and protect chemo’s primacy as a cancer treatment. And given the government’s attitude, one can only wonder if the results of the trial will ever see the light of day.

Why then is the FDA denying patients access to a potentially lifesaving treatment when nothing else works? These are exactly the kinds of situations that compassionate use and expanded access were made for—patients with no other options who want access to experimental treatments. But rather than give patients one last chance, the FDA effectively signs their death warrant by denying access to Dr. Burzynski’s antineoplaston treatment. This has to stop.

[Read more here]


Robert O'Leary 150x150Robert O’Leary, JD BARA, has had an abiding interest in alternative health products & modalities since the early 1970’s & he has seen how they have made people go from lacking health to vibrant health. He became an attorney, singer-songwriter, martial artist & father along the way and brings that experience to his practice as a BioAcoustic Soundhealth Practitioner, under the tutelage of the award-winning founder of BioAcoustic Biology, Sharry Edwards, whose Institute of BioAcoustic Biology has now been serving clients for 30 years with a non-invasive & safe integrative modality that supports the body’s ability to self-heal using the power of the human voice. Robert brings this modality to serve clients in Greater Springfield (MA), New England & “virtually” the world, with his website, www.romayasoundhealthandbeauty.com. He can also be reached at romayasoundhealth andbeauty@gmail.com.



Tags: , , , , , , ,


If you enjoyed this article, subscribe now to receive more just like it.

Subscribe via RSS Feed Connect on YouTube

5 Reader Comments

Trackback URL Comments RSS Feed

  1. 10207982358017821@facebook.com' Mayaman Ako says:

    How about cannabis oil instead…

  2. 222024518165750@facebook.com' Giả Cầy says:

    I likeConscious Life News…I got 12 percent, join now…
    5pVkDps o.O Play here. ==> https://goo.gl/UJyCKv

    Tks ad with post: The FDA is effectively signing the death warrant of more patients by denying them access to Dr. Burzynski’s antineoplaston cancer treatment—for no rational reason whatsoever. Please help. Action A…

  3. 960797077346073@facebook.com' Richard Jensen says:

    Cure Big Pharma of greed and you cure cancer.

  4. 10209483388103466@facebook.com' Gerald Richard says:

    The FDA has no intention of allowing any substance that may be a cure especially for their cash cow, Cancer or HIV. Our medical system is flawed, Doctors should be payed according to the Health of their clients. All about money.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

FAIR USE NOTICE. Many of the articles on this site contain copyrighted material whose use has not been specifically authorized by the copyright owner. We are making this material available in an effort to advance the understanding of environmental issues, human rights, economic and political democracy, and issues of social justice. We believe this constitutes a 'fair use' of the copyrighted material as provided for in Section 107 of the US Copyright Law which contains a list of the various purposes for which the reproduction of a particular work may be considered fair, such as criticism, comment, news reporting, teaching, scholarship, and research. If you wish to use such copyrighted material for purposes of your own that go beyond 'fair use'...you must obtain permission from the copyright owner. And, if you are a copyright owner who wishes to have your content removed, let us know via the "Contact Us" link at the top of the site, and we will promptly remove it.

The information on this site is provided for educational and entertainment purposes only. It is not intended as a substitute for professional advice of any kind. Conscious Life News assumes no responsibility for the use or misuse of this material. Your use of this website indicates your agreement to these terms.

Paid advertising on Conscious Life News may not represent the views and opinions of this website and its contributors. No endorsement of products and services advertised is either expressed or implied.
Send this to a friend